Crosstalk between OPG/RANKL/RANK in bone marrow mesenchymal stem cells and Wnt/b-catenin pathway in prostate cancer cells regulates bone metastasis of prostate cancer
Polish Journal of Pathology · 2025
DOI: 10.5114/pjp.2025.150029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polish Journal of Pathology, 2025. Verfasst von Shihua Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Mindong Hospital Affiliated to Fujian Medical University, Fuan City, Ninde, Fujian, 355000, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, RANK Ligand, Bone Neoplasms, Osteoprotegerin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
This study aimed to investigate whether the crosstalk between the osteoprotegerin (OPG)/receptor activator of nuclear factor-kB (RANK)/receptor activator of nuclear factor-kB ligand (RANKL) in bone marrow mesenchymal stem cells (BMSCs) and Wnt/b-catenin pathways in Pca cells regulates bone metastasis of PCa.
Our study showed that there was increased OPG/RANKL/RANK and b-catenin expression in the tissue of PCa and its bone metastasis. This study further showed that RANKL knockdown in BMSCs or b-catenin knockdown in PC-3s blocked the proliferation and migration of BMSCs and the proliferation, migration, and invasion of PC-3s in vitro. Conversely, RANKL overexpression in BMSCs and b-catenin overexpression in PC-3s promoted the proliferation and migration of BMSCs and the proliferation, migration, and invasion of PC-3s in vitro. These data indicate that the RANKL pathway in BMSCs promoted the PC-3s invasion and the catenin pathway in PC-3s activated BMSCs with expression of cancer-associated fibroblast markers, which promoted the bone metastasis.
This suggests that the interaction and crosstalk between BMSCs in bone microenvironment and PCa play a critical role in the exquisite tropism for Pca bone metastasis. Cancer therapies classically target tumour cells; however, based on this study, targeting BMSCs in bone microenvironment is a reasonable option for PCa therapy strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Mindong Hospital Affiliated to Fujian Medical University, Fuan City, Ninde, Fujian, 355000, China.
Zitieren
APA
Ye, S., Lin, Q., Deng, M., Huang, S., Mao, C., Zhang, J., Zhan, W., & Chen, G. (2025). Crosstalk between OPG/RANKL/RANK in bone marrow mesenchymal stem cells and Wnt/b-catenin pathway in prostate cancer cells regulates bone metastasis of prostate cancer. Polish Journal of Pathology. https://doi.org/10.5114/pjp.2025.150029
Vancouver
Ye S, Lin Q, Deng M, Huang S, Mao C, Zhang J, et al. Crosstalk between OPG/RANKL/RANK in bone marrow mesenchymal stem cells and Wnt/b-catenin pathway in prostate cancer cells regulates bone metastasis of prostate cancer. Polish Journal of Pathology. 2025. doi:10.5114/pjp.2025.150029
BibTeX
@article{Ye2025,
author = {Ye, Shihua and Lin, Qiongyun and Deng, Meihua and Huang, Shulong and Mao, Changlin and Zhang, Jiabin and Zhan, Wuming and Chen, Guangbing},
title = {Crosstalk between OPG/RANKL/RANK in bone marrow mesenchymal stem cells and Wnt/b-catenin pathway in prostate cancer cells regulates bone metastasis of prostate cancer},
journal = {Polish Journal of Pathology},
year = {2025},
doi = {10.5114/pjp.2025.150029}
}
EUVIMED